Outcomes of Gemcitabine, Oxaliplatin, and Paclitaxel Salvage Chemotherapy in Japanese Patients With Relapsed or Refractory Germ Cell Tumors
Year: 2026
Type: article
Study design: Observational Study
Source: International Journal of Urology
DOI: 10.1111/iju.70560
Institution: Kanagawa Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166889255
